beta

ALPN

Alpine Immune Sciences Inc.

Alpn

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Nivalis Therapeutics Inc a pharmaceutical company, focuses on the discovery and development of product candidates for patients with cystic fibrosis. Geographically operation of the group is functioned through United States.

Market Cap: 161 Million

Primary Exchange: NASDAQ Global Market

Website: https://www.alpineimmunesciences.com

Shares Outstanding: 13.9 Million

Float: 13.7 Million

Dividend: 0.0 (0.0%)

Beta: 0.24637

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 31.6 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1037 trading days

From: 2015-08-21 To: 2019-10-11

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-07-25 4.0 1.0 4.0
Data provided by IEX Cloud